Substance
RIVAROXABAN
Global reference: every product and company linked to this substance.
- cas: 366789-02-8
- ncit: C77995
- pubchem_cid: 9875401
- rxnorm: 1114195
- unii: 9NDF7JZ4M3
BAY-59-7939 · BAY59-7939 · JNJ-39039039 · JNJ39039039 · Rivaroxaban [INN] · Rivaroxaban [JAN] · Rivaroxaban [USAN] · Rivaroxaban [WHO-DD] · XARELTO
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| JOHNSON & JOHNSON COMMON STOCK | XARELTO | Q2 2026 | $664.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (2)
- RIVAROXABAN · DR. REDDY'S LABORATORIES LTD COMMON STOCK
- XARELTO · JOHNSON & JOHNSON COMMON STOCK